Neuberger Berman Group LLC Has $18.26 Million Stock Position in Avantor, Inc. (NYSE:AVTR)

Neuberger Berman Group LLC reduced its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 7.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 866,751 shares of the company's stock after selling 70,919 shares during the period. Neuberger Berman Group LLC owned approximately 0.13% of Avantor worth $18,262,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently made changes to their positions in the business. Vanguard Group Inc. raised its holdings in shares of Avantor by 1.9% during the 4th quarter. Vanguard Group Inc. now owns 63,969,754 shares of the company's stock worth $1,347,843,000 after buying an additional 1,211,418 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC boosted its position in shares of Avantor by 41.4% during the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 30,528,092 shares of the company's stock worth $643,227,000 after purchasing an additional 8,936,879 shares in the last quarter. Geode Capital Management LLC increased its stake in Avantor by 0.7% during the 4th quarter. Geode Capital Management LLC now owns 11,232,329 shares of the company's stock valued at $236,227,000 after purchasing an additional 81,541 shares in the last quarter. Invesco Ltd. boosted its position in shares of Avantor by 3.4% during the fourth quarter. Invesco Ltd. now owns 9,785,138 shares of the company's stock valued at $206,173,000 after buying an additional 317,280 shares during the last quarter. Finally, Bessemer Group Inc. increased its stake in Avantor by 15.9% in the 4th quarter. Bessemer Group Inc. now owns 8,868,903 shares of the company's stock valued at $186,868,000 after buying an additional 1,218,589 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company's stock.

Remove Ads

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on AVTR shares. UBS Group reiterated a "neutral" rating and issued a $25.00 target price (down previously from $29.00) on shares of Avantor in a research note on Friday, January 17th. Barclays reduced their price objective on Avantor from $23.00 to $18.00 and set an "overweight" rating on the stock in a research note on Thursday, April 10th. Morgan Stanley cut their price target on shares of Avantor from $27.00 to $25.00 and set an "overweight" rating on the stock in a report on Monday, February 10th. Cowen restated a "buy" rating on shares of Avantor in a report on Tuesday, March 18th. Finally, Raymond James reissued an "outperform" rating and set a $24.00 price objective (down previously from $26.00) on shares of Avantor in a research note on Monday, February 10th. Three analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to data from MarketBeat.com, Avantor presently has an average rating of "Moderate Buy" and a consensus target price of $25.08.

Insider Buying and Selling

In other Avantor news, CAO Steven W. Eck sold 4,907 shares of the company's stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $86,019.71. Following the transaction, the chief accounting officer now directly owns 40,604 shares in the company, valued at approximately $711,788.12. This represents a 10.78 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP James Bramwell sold 3,758 shares of the stock in a transaction that occurred on Wednesday, February 26th. The shares were sold at an average price of $17.53, for a total transaction of $65,877.74. Following the completion of the sale, the executive vice president now owns 87,379 shares in the company, valued at $1,531,753.87. This represents a 4.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

Avantor Stock Performance

Shares of NYSE AVTR traded down $0.03 during trading on Wednesday, reaching $15.37. 3,035,710 shares of the company traded hands, compared to its average volume of 6,875,687. The firm's fifty day simple moving average is $16.54 and its 200 day simple moving average is $20.33. The stock has a market cap of $10.47 billion, a P/E ratio of 14.78, a PEG ratio of 1.55 and a beta of 1.24. Avantor, Inc. has a 12-month low of $13.80 and a 12-month high of $28.00. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54.

Avantor (NYSE:AVTR - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, beating the consensus estimate of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same period in the prior year, the company posted $0.22 earnings per share. As a group, research analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.